Joint publication by Matthias Feige and Kathrin Schumann: Human interleukin-12α and EBI3 are cytokines with anti-inflammatory functions

Read More

Joint publication by Ulrike Protzer and Matthias Feige: Modeling of the human interleukin 12:receptor complex allows to engineer attenuated cytokine variants

Read More

New publication of Marion Subklewe in Cancer Immunology Research: “Influence of adipose tissue distribution, sarcopenia and nutritional status on clinical outcomes after CD19 CAR T-cell therapy”

Read More

New publication by Veit Buchholz in nature

Read More

New publication on cytotoxic T cells in SARS-CoV2 infection

Read More

LETSimmun

Lymphocyte Engineering for Therapeutic Synthetic Immunity

Adoptive T cell therapy has advanced to become a distinguished and rapidly evolving translational research field in modern medicine. This collaborative research center (CRC) transregio (TRR) LETSIMMUN is setting out to become a hot spot for cutting-edge basic and translation research in Lymphocyte Engineering in Germany, and aspires to deliver novel concepts and cell products for clinical development that provide Therapeutic Synthetic Immunity for patients.

More

Events

See All

Projects

LETSimmun comprises eighteen scientific projects that focus on three principal research areas and three central projects. More

People

LETSimmun brings experienced researchers and clinician-scientists together with young talents and interdisciplinary experts. More

For Members

Download area for LETSimmun members More

News

Here you can find the latest news regarding our research project. More

IRTG

The Integrated Research Training Group supports the education of young scientistsin the field of lymphocyte engineering. More

Gender Measures

LETSimmun is committed to improving the gender gap in science and taking actions against any form of disadvantages and discrimination. More

I

Play Video

CAR-T cells at work: in vivo imaging of CAR T cells in Primary CNS Lymphoma

INSTITUTIONS